Genetic Technology Alert. Cancerous Growth Inhibited by a Kinase Inhibitor; Patient-Driven Oncological Therapeutic Solutions Using Cancer Genomic Foundation; Multiple Kinase Inhibitors Targeting Oncological Disorders Currently in Clinical Trials

RELEASE DATE
22-May-2015

REGION
Global

Deliverable Type
Technology Alert

Research Code: D756-00-93-00-00

SKU: HC02718-GL-TA_19612

$250.00

In stock

SKU

HC02718-GL-TA_19612

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Description
Table of Contents
Request Sample

Description

This issue profiles cancerous growth inhibited by a kinase inhibitor, patient-driven oncological therapeutic solutions using cancer genomic foundation, and multiple kinase inhibitors targeting oncological disorders that are currently in clinical trials.

Genetic Technology Alert. Cancerous Growth Inhibited by a Kinase Inhibitor; Patient-Driven Oncological Therapeutic Solutions Using Cancer Genomic Foundation; Multiple Kinase Inhibitors Targeting Oncological Disorders Currently in Clinical Trials

In This Issue

1. CANCEROUS GROWTH INHIBITED BY A KINASE INHIBITOR
2. PATIENT-DRIVEN ONCOLOGICAL THERAPEUTIC SOLUTIONS USING CANCER GENOMIC FOUNDATION
3. MULTIPLE KINASE INHIBITORS TARGETING ONCOLOGICAL DISORDERS CURRENTLY IN CLINICAL TRIALS
4. KEY PATENTS ACROSS KINASE INHIBITORS
5. TECHVISION 2015

Request Sample